Skip to content

Application of Shear Wave Elastography and Artificial Intelligence in the examination and treatment of intrauterine adhesions

Application research of Shear Wave Elastography combined with Artificial Intelligence in the diagnosis and treatment of intrauterine adhesions

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115658
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Adhesions

Interventions

Normal control group:None
Mild IUA group:None
Moderate IUA group:None
Severe IUA group:None

Sponsors

Chongqing Health Center for Women and Children
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Control group: Age 18–40 years, with fertility requirements; regular menstrual cycles (21–35 days); undergoing hysteroscopy for other benign lesions (e.g., a single endometrial polyp <2 cm in diameter not involving the fundus or cornua), with intraoperative confirmation of no uterine adhesions; preoperative 3D ultrasound showing regular uterine cavity morphology and continuous endometrial line without interruption; postoperative pathology of the polyp confirmed as benign with no need for hormonal therapy; signed informed consent and voluntarily participated in this study. 2. IUA disease group: Age 18–40 years, with fertility requirements; regular menstrual cycles (21–35 days); diagnosed with IUA via outpatient or inpatient hysteroscopy and planned for TCRA surgery; signed informed consent and voluntarily participated in this study.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating; 2. History of hormone use within the past 3 months (e.g., oral contraceptives, progestogens); 3. Concurrent malignant or suspected malignant endometrial lesions; 4. Concurrent other uterine conditions that may severely affect uterine cavity morphology or interfere with SWE measurements, such as large fibroids (diameter >4 cm), diffuse or severe adenomyosis; 5. History of pelvic radiation or chemotherapy; 6. Known systemic connective tissue disease; 7. Inability to cooperate with transvaginal ultrasound examination.

Design outcomes

Primary

MeasureTime frame
SWE Diagnostic Efficacy (Grading of IUA Severity);IUA Recurrence Rate;

Secondary

MeasureTime frame
Postoperative Pregnancy Outcomes;AI Model Predictive Efficacy (Natural Pregnancy Rate within 1 Year Post-surgery);Correlation between SWE Parameters and Adhesion Tissue Pathology;Postoperative Menstrual Volume Improvement;

Countries

China

Contacts

Public ContactChi Yugang

Chongqing Health Center for Women and Children

chiyugang@163.com+86 23 63316835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026